Three-for-one Lilly shifted the market when it released its last blockbuster weight loss medication, tirzepatide (Zepbound/Mounjaro)
Suitable for adults with a BMI of 30 or greater (or 27 and above with related conditions), Wegovy has shown promising results in trials, offering an average weight loss of 15% over 68 weeks
Cons: only delivers B12, no hydration, no other vitamins, no add-ons
If you are currently suffering with any infections, are taking antibiotics or have current cold and flu symptoms, then having the Vitamin B12 shot at that time is contraindicated
Self-administering retatrutide outside a clinical trial carries serious risks including infection, product impurity, incorrect dosing, and lack of pharmacovigilance protection
There are currently 6 medications (orlistat, naltrexone-bupropion, liraglutide, semaglutide, tirzepatide, and phentermine-topiramate) that have been approved for the treatment of obesity in adults [8, 9]